Navigation Links
Unique US-Chinese lab to head off H7N9 outbreak and future threats
Date:5/28/2013

The Center for Infection and Immunity at Columbia University's Mailman School of Public Health (CII) and the National Institute for Viral Disease Control and Prevention (NIVDC) within the Chinese Center for Disease Control and Prevention will open a Joint Research Laboratory for Pathogen Discovery to conduct surveillance, identify new infectious microbes, establish novel platforms for diagnostics, and develop drugs and vaccines to treat diseases in humans and animals.

It is the first time an international team will operate a laboratory within the Chinese Center for Disease Control. The agreement, years in the making and formalized on May 9, will "enable CII and Chinese CDC investigators to work side-by-side developing solutions for pandemic threats to global health" says Dr. W. Ian Lipkin, MD, Director of CII.

The unique arrangement had its origins 10 years ago when Dr. Lipkin was invited by the government of China to help address the challenge of SARS. Together with Chinese scientists and officials, he developed a research plan for SARS and infectious disease control, and even appeared on Chinese television to allay fears and correct misconceptions regarding treatments.

"In 2013 the threat is not the SARS coronavirusthis time the imminent threats are the H7N9 influenza virus and the new coronavirus emerging in the Middle East," says Dr. Lipkin, who serves a Scientific Director of the laboratory along with Xiao-ping Dong, MD, and Administrative Director Zhao-jun Duan, PhD, of the NIVDC.

"This historic agreement comes at a crucial time. International collaboration is needed in the face of infectious disease outbreaks with the potential to rapidly cross borders and spread around the world," says Dr. Dong.

Expected to be operational by in the summer of 2013, the new laboratory will employ state-of-the-art techniques to keep up with the rapidly increasing pace of pathogen discovery, which has been spurred by a global proliferation of microbial infections and improvements in methods for detection. New molecular diagnostic platforms; investments in pathogen surveillance in wildlife, domestic animals and humans; and the advent of social media tools that mine the Internet for clues to outbreaks of infectious disease are proving invaluable in early recognition of threats to public health.

The new lab will open its doors at a time when pathogen discovery is pushing the boundaries of what is thought of as infectious disease by lending insights into the mechanisms by which microbes can contribute to chronic illnesses like cancer, peptic ulcer disease, and mental illness.

Through a five-year agreement between Columbia and NIVDC, the lab will be funded by NIVDC.


'/>"/>

Contact: Timothy S. Paul
tp2111@columbia.edu
212-305-2676
Columbia University's Mailman School of Public Health
Source:Eurekalert

Related biology news :

1. New study identifies unique mechanisms of antibiotic resistance
2. Sex differences in the normal composition of the heart may explain unique gender outcomes
3. Study: Antibiotics are unique assassins
4. Unique peptide could treat cancers, neurological disorders, and infectious diseases
5. Birdsong study pecks theory that music is uniquely human
6. German Research Foundation to fund globally unique twin study on social inequality
7. East Asia faces unique challenges, opportunities for stem cell innovation
8. Duke Medicine news -- Genome sequencing of Burkitt Lymphoma reveals unique mutation
9. Iowa State, Ames Lab researchers find 3 unique cell-to-cell bonds
10. Oil from algae closer to reality through studies by unique collaboration of scientists
11. Rare cliffhanging plant species uses unique reproductive strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
(Date:3/9/2017)... , March 9, 2017 4Dx has publicly ... Lung Imaging Workshop at the University of Pennsylvania. Founder ... to deliver the latest data to world leaders in ... brings together leaders at the forefront of the industry ... imaging. "The quality of the imaging ...
(Date:3/7/2017)... March 7, 2017   HireVue , the leading ... companies identify the best talent, faster, today announced the ... Officer (CSO) and Diana Kucer as Chief ... seasoned executive team poised to drive continued growth in ... a year of record bookings in 2017. ...
Breaking Biology News(10 mins):
(Date:3/28/2017)...  Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ... for metabolic and endocrine disorders, today announced that its ... deliver a corporate presentation at H.C. Wainwright & Co.,s ... April 3, 2017 at the St. Regis Hotel in ... are as follows: H.C. Wainwright ...
(Date:3/28/2017)... NEW YORK , March 28, 2017 /PRNewswire/ ... a highly volatile and unpredictable sector due to ... space. Markets served include medical, agricultural, environmental, and ... these four stocks: Portola Pharmaceuticals Inc. (NASDAQ: PTLA), ... OCRX), and Ocular Therapeutix Inc. (NASDAQ: ...
(Date:3/27/2017)... March 27, 2017 Roka Bioscience, Inc. (NASDAQ: ROKA), ... for the detection of foodborne pathogens,  today announced that ... Company Spring 2017 Convention on March 29 at 9:50am ET. ... Marquis. About Roka Bioscience ... Roka Bioscience is ...
(Date:3/27/2017)... March 27, 2017  The global market for ... according to a new report from Kalorama Information.  ... is performed to evaluate disease progression, monitor drug ... other reasons.  The healthcare market research firm,s report, ... provides an overview of the medical laboratory industry ...
Breaking Biology Technology: